e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation
This seminar shows pharma teams how to use AI to create evidence-based content and strong cross-channel brand narratives. Through practical frameworks, real use cases and hands-on exercises, participants learn how to scale content efficiently while staying fully compliant. Ideal for marketers who want to apply AI safely and effectively in daily work.
Compact overview of EU requirements for labelling, UDI and product information under the MDR. Learn how legal obligations translate into practical workflows, including UDI allocation and EUDAMED device registration. Ideal for RA, QA and labelling professionals.
Enable teams to plan and run unbranded, non-promotional disease awareness campaigns that inform the public responsibly, remain clearly separate from product promotion, and are ready for EU-wide deployment.
This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital transformation and evidence generation. Expect focused insights, practical takeaways and lively discussions with experienced speakers - and stay informed about the latest developments in global regulatory practices.
Biosimilar uptake in Europe, Aut idem in Germany - these are the challenges for regulatory affairs and market access
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essential market access areas covered
Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.
This two-day online seminar gives newcomers to pharma marketing a solid, practice-oriented foundation. Participants learn how to translate insights into strategy, understand Market Access and digital basics, and develop compliant, evidence-based content. Ideal for those starting out or moving into marketing from adjacent roles.
This seminar covers the key regulatory shifts shaping the biosimilars landscape in 2026. Explore how the revised EU pharmaceutical legislation, the EU Biotech Act, and global regulatory convergence impact your biosimilar development and market entry strategy.
This seminar gives you a clear, comparative understanding of how innovative pricing and reimbursement agreements are structured and negotiated across the UK, Italy, France, Spain, and Germany.
